Skip to main content
OpenTrials

Clinical trial condition

High-Risk Localized Prostate Cancer

Explore clinical trials studying High-Risk Localized Prostate Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

High-Risk Localized Prostate Cancer trial results

Recruiting

A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.

NCT07450599

Conditions
High-Risk Localized Prostate Cancer
Locations
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking University First Hospital - Oncology Department Beijing, Beijing Municipality, China
  • Fujian Medical University - The First Affiliated Hospital Fuzhou, Fujian, China
View all 23 locations
View Trial Details